We are live on ! Find out more
CIBC Private Wealth Group

CIBC Private Wealth Group Portfolio holdings

AUM $59.2B
1-Year Est. Return 20.62%
This Fund
S&P 500
This Quarter Est. Return
+1.41%
1 Year Est. Return
+20.62%
3 Year Est. Return
+88.19%
5 Year Est. Return
+111.32%
10 Year Est. Return
+389.71%
AUM
$43B
AUM Growth
-$554M
Cap. Flow
-$798M
Cap. Flow %
-1.86%
Top 10 Hldgs %
26.98%
Holding
1,070
New
48
Increased
266
Reduced
478
Closed
143

Sector Composition

Rank Sector Weight
1 Technology 23.77%
2 Financials 15.93%
3 Healthcare 13.08%
4 Consumer Discretionary 9.62%
5 Industrials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDOC icon
901
Teladoc Health
TDOC
$1.61B
$202K ﹤0.01%
1,596
-97,586
-98% -$14.2M
OTRK
902
DELISTED
Ontrak
OTRK
$188K ﹤0.01%
208
-3
-1% -$5.36K
MRCC
903
DELISTED
Monroe Capital Corp
MRCC
$184K ﹤0.01%
17,676
AXDX
904
DELISTED
Accelerate Diagnostics
AXDX
$174K ﹤0.01%
2,978
-100
-3% -$6.52K
AM icon
905
Antero Midstream
AM
$10.4B
$166K ﹤0.01%
15,887
-75,606
-83% -$741K
GLQ
906
Clough Global Equity Fund
GLQ
$153M
$161K ﹤0.01%
+11,000
New +$167K
AGNC icon
907
AGNC Investment
AGNC
$12.4B
$158K ﹤0.01%
10,000
-112
-1% -$1.81K
BDJ icon
908
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.7B
$147K ﹤0.01%
14,954
+162
+1% +$1.64K
ATEC icon
909
Alphatec Holdings
ATEC
$1.33B
$143K ﹤0.01%
11,754
+1,350
+13% +$18.8K
CNX icon
910
CNX Resources
CNX
$4.77B
$137K ﹤0.01%
10,884
SHLX
911
DELISTED
Shell Midstream Partners, L.P.
SHLX
$135K ﹤0.01%
11,500
OCUL icon
912
Ocular Therapeutix
OCUL
$1.89B
$120K ﹤0.01%
12,040
OXLC
913
Oxford Lane Capital
OXLC
$824M
$112K ﹤0.01%
3,100
VUZI icon
914
Vuzix
VUZI
$193M
$105K ﹤0.01%
10,004
-1,103
-10% -$14.8K
ARYD
915
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$101K ﹤0.01%
10,000
AIHS icon
916
Senmiao Technology Ltd
AIHS
$20.8M
$82K ﹤0.01%
1,394
TCRT icon
917
Alaunos Therapeutics
TCRT
$4.71M
$75K ﹤0.01%
275
+3
+1% +$917
LSTA icon
918
Lisata Therapeutics
LSTA
$13.1M
$68K ﹤0.01%
3,702
HGEN
919
DELISTED
HUMANIGEN, INC.
HGEN
$59K ﹤0.01%
10,000
CRMD icon
920
CorMedix
CRMD
$596M
$56K ﹤0.01%
12,000
PPT
921
Franklin Premier Income Trust
PPT
$323M
$49K ﹤0.01%
10,680
-5,624
-34% -$25.9K
DARE icon
922
Dare Bioscience
DARE
$19.8M
$42K ﹤0.01%
2,083
SNT
923
Senstar Technologies
SNT
$41.3M
$39K ﹤0.01%
10,000
SMTS
924
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$31K ﹤0.01%
17,135
PTN
925
Palatin Technologies
PTN
$13.9M
$25K ﹤0.01%
46

Similar funds

CIBC Private Wealth Group's Q3 2021 Portfolio in Review

As of Q3 2021, CIBC Private Wealth Group held 1,070 positions worth $43B, down 1.3% from $43.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

CIBC Private Wealth Group's Q3 2021 filing shows 48 new, 266 increased, 478 reduced and 143 closed positions. Its largest new stake was GXO Logistics: 1,346,282 shares worth $106M. The largest sale was Texas Instruments, an estimated $202M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • CIBC Private Wealth Group's largest Q3 2021 buy was GXO Logistics: 1,346,282 shares worth $106M.
  • CIBC Private Wealth Group added most to Palo Alto Networks in Q3 2021, an estimated $116M increase.
  • CIBC Private Wealth Group's biggest Q3 2021 reduction was Texas Instruments, cutting an estimated $202M.
  • CIBC Private Wealth Group fully exited Rice Acquisition Corp. in Q3 2021, selling an estimated $38.4M.
  • CIBC Private Wealth Group's ten largest holdings make up 27% of its $43B portfolio in Q3 2021.
  • CIBC Private Wealth Group opened 48 new positions and closed 143 in Q3 2021.
  • CIBC Private Wealth Group's portfolio value fell 1.3% quarter-over-quarter to $43B.

Based on CIBC Private Wealth Group's 13F filing for Q3 2021, filed 12 Nov 2021.